This legislation aims to enhance the management of prescription drug benefits under Medicare and Medicaid, particularly by regulating pharmacy benefit managers (PBMs). The primary goal is to ensure fair pricing and improved access to medications for patients, while also increasing transparency and accountability in the drug pricing system. Key provisions include new requirements for PBMs that will take effect in 2027.